# Greater Baltimore Medical Center – FDA Inspection, Oct 26, 2023

Source: https://www.keypedia.com/records/fda_inspections/greater-baltimore-medical-center/a35a99c8-91a0-4a86-a3ca-a4f20aa62689
Source feed: FDA_Inspections

> FDA inspection 1221203 of Greater Baltimore Medical Center, October 26, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 606. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221203
- Company Name: Greater Baltimore Medical Center
- Inspection Date: 2023-10-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1305080 - 2026-02-05
- FDA Inspection 1121801 - 2019-11-01
- FDA Inspection 1038518 - 2017-12-08
- FDA Inspection 982274 - 2016-07-14
- FDA Inspection 862071 - 2014-01-15

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/richard-j-bashay/ce50702d-1f5b-42c5-b50a-88bb43cba196)

Company: https://www.keypedia.com/companies/greater-baltimore-medical-center/252bbb07-3732-43c3-a3ee-eccd341f8dc9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
